Q1 FY27 results: revenue up 14% YoY to Rs 662 cr; board approves KVPL unit divestment
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 16.0 pts more than Nifty Microcap 250 and 16.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar Q1 FY27: revenue Rs 662 cr up 14% YoY, net profit Rs 45 cr vs Rs 26 cr, EPS Rs 3.28. Profit includes Rs 30 cr exceptional insurance gain from 2024 Vashivali plant fire. Board also approved selling wholly owned subsidiary Keva Ventures to promoter group firm Keva Aromatics for Rs 45.85 lakh. KVPL and its sub Amikeva are non-core, contributing under 0.1% of consolidated sales. Deal to close by Dec 31, 2026.
Strong Q1 results with revenue and profit growth, aided by insurance gain. KVPL sale is a minor non-core divestment to promoter group with minimal financial impact.